All supplements

Supplement evidence

112 / 575Joint & connective tissue

Oral hyaluronic acid

View my plan

The short answer

Early trials examine knee and skin outcomes; effects and optimal dose remain uncertain.

Evidence and scope
Emerging evidence

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Early human findings are hypothesis-generating; efficacy, long-term safety, and optimal dose remain uncertain.
Before deciding
Key concern: Cancer treatment, pregnancy, allergies, and product molecular weight require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Joint symptoms80–240 mg/day in small trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityWater-soluble

Water-soluble or readily water-dispersible. This does not mean excess is always harmless.

How it is commonly taken

May be taken with or without food.

Do not combine casually

Cancer treatment, pregnancy, allergies, and product molecular weight require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger
11unique primary studies represented
597unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2024
Mixed or qualifiedPMID 39886281

Oral hyaluronic acid for osteoarthritis and low back pain

Nine of 11 articles reported at least one improvement and adverse effects were rare and mild, but the review did not establish pooled effect size, trial quality, or protection of cartilage. Low-back-pain evidence came from one study.

Study design and methods
Design
Systematic review of 11 articles
Population
597 adults, 10 studies in osteoarthritis and 1 in low back pain
Intervention
Oral hyaluronic acid 30–300 mg/day
Outcome
Pain, WOMAC, joint function, quality of life, stiffness, and inflammatory markers

Funding or conflict note: The review reported no conflicts of interest.

Open research record
Unscreened discovery appendix—not evidence5 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Oral Hyaluronic Acid Supplement: Efficacy in Skin Hydration, Elasticity, and Wrinkle Depth Reduction.Amin P, Sarabi A, Choe S et al. · 2025 · Journal of drugs in dermatology : JDD · PMID 40911749Open on PubMed
  2. A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis.Hill WS, Dohnalek MH, Ha Y et al. · 2023 · Nutrients · PMID 37686801Open on PubMed
  3. The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses.Nelson FR, Zvirbulis RA, Zonca B et al. · 2015 · Rheumatology international · PMID 24899570Open on PubMed
  4. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period.Tashiro T, Seino S, Sato T et al. · 2012 · TheScientificWorldJournal · PMID 23226979Open on PubMed
  5. Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial.Kalman DS, Heimer M, Valdeon A et al. · 2008 · Nutrition journal · PMID 18208600Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.